Psychotherapy, Psychiatry and the Drug Industry

Authors

  • Robert Maxwell Young

DOI:

https://doi.org/10.1234/fa.v0i68.127

Keywords:

pharmacology, psychotherapy, drug industry, corruption

Abstract

Drawing on personal and professional experience, this article explores the debate aorund the relative efficacies of drugs and psychotherapy. It charts the demise of psychotherapy as a preferred psychological intervention in the medical setting and provides extensive evidence of the ideological motivations underpinning the entrenchment of a pharmaceutical-based model in the treatment of mental health issues. It spells out the benefits of psychotherapy and advocates resistance to the drug-based policies that currently dominate.

Downloads

Published

2015-12-08

How to Cite

Young, R. M. (2015). Psychotherapy, Psychiatry and the Drug Industry. Free Associations, (68), 1–30. https://doi.org/10.1234/fa.v0i68.127

Issue

No. 68 (2015)

Section

Articles

License

Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).